Copyright
©The Author(s) 2021.
World J Gastroenterol. Sep 7, 2021; 27(33): 5502-5519
Published online Sep 7, 2021. doi: 10.3748/wjg.v27.i33.5502
Published online Sep 7, 2021. doi: 10.3748/wjg.v27.i33.5502
Figure 3 Number of deaths from coronavirus disease 2019 per 100000 habitants and nonalcoholic fatty liver disease prevalence.
United Kingdom 150.94, Czechia 146.98, Italy 143.01, United States of America 129.94, Peru 125.38, Spain 121.55, Mexico 120.47, France 110.84, Portugal 107.10, Argentina 106.20.
- Citation: Campos-Murguía A, Román-Calleja BM, González-Regueiro JA, Hurtado-Díaz-de-León I, Solís-Ortega AA, Flores-García NC, García-Juárez I, Ruiz-Margáin A, Macías-Rodríguez RU. Clinical perspectives, assessment, and mechanisms of metabolic-associated fatty liver disease in patients with COVID-19. World J Gastroenterol 2021; 27(33): 5502-5519
- URL: https://www.wjgnet.com/1007-9327/full/v27/i33/5502.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i33.5502